INS and diabetes mellitus: Exogenously administered insulin is a critical tool in the management of diabetes—in 2021, the Centers for Disease Control and Prevention (CDC) reported that 12.3% of all United States adults with diabetes started using insulin within a year of their diagnosis [9].